Respiratory Infections

The FDA advisory committee voted 17 to 1 in favor of omadacycline for treatment of ABSSSI and 14 to 4 for the treatment of CABP.

If approved, ALIS will be the first and only therapy available in the United States that will be specifically indicated for the treatment of patients with NTM lung disease caused by MAC.

Investigators report that the duration of viral shedding of influenza A in obese adults was 42% longer than nonobese adults.

New research suggests 4 months of rifampin produced higher rates of adherence than 9 months of isoniazid in individuals with latent tuberculosis.

With vaccine efficacy during the 2017–2018 flu season under question, a novel antiviral agent may provide a solution.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Gram-negative organisms are showing up at higher rates in seriously ill pneumonia patients. What are the best antibiotics to prescribe, given the real risk of death and the need to avoid contributing to drug resistance?

A recent report shows that patients receiving eculizumab remain extremely susceptible to meningococcal disease, including from nongroupable Neisseria meningitidis strains, despite being vaccinated against the disease.

Genentech has announced that baloxavir marboxil met primary objective in the phase 3 CAPSTONE-2 study for individuals with a high risk of complications from influenza.

New data indicate that urgent care centers prescribed antibiotics for 45.7% patients with respiratory infections associated with inappropriate antibiotic prescribing.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

In case you missed them, we’ve compiled the top 5 infectious disease articles from this past week.

A new study observed that the type of pertussis vaccine used to prime the immune system in childhood has a lasting effect on an individual’s future immune response.

Johns Hopkins Hospital evacuates over tuberculosis concerns.

Stay up-to-date on the latest infectious disease news by reading the top 5 articles of the week.

CDC researchers say that some influenza respiratory infections may be originating in the eye, and thus, more research is needed pertaining to ocular transmission.

New CDC recommendations include the use of 3HP in children and individuals with LTBI who have HIV infection, including AIDS.

Doctors are prescribing antibiotics too often for viral acute respiratory infections.

Experts continue to recommend that people get the seasonal flu vaccine as the scientific community works toward a universal vaccine offering lifelong protection against multiple strains.

The FDA has accepted an NDA and granted Priority Review for Genentech’s baloxavir marboxil for the treatment of acute, uncomplicated influenza in individuals aged 12 and older.

Researchers find that testing pregnant mothers for the respiratory syncytial virus is rare and can often result in a misdiagnosis of pneumonia.

A UNC study suggests receiving the Tdap vaccine during pregnancy could close the gap of vulnerability to pertussis between birth and the first DTaP vaccination.

The American Society for Microbiology’s (ASM) annual meeting, held June 7-11, 2018, in Atlanta, Georgia, featured results of numerous studies on and advancements being made in infectious diseases. Here are 5 key takeaways from the meeting.

Researchers from the Chang-Gung Memorial Hospital find that half of influenza cases in patients admitted to the ICU received a false-negative rapid influenza antigen test.

Anne Schuchat, MD, provides some history and insights on CDC’s role in safeguarding public health when the microbial world collides with the human world.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The overall rate of health care personnel receiving flu shots has gone up in recent years, but a new study finds that much of the increase is due to policies held at non-VA hospitals.

The FDA has approved Lannet Company’s Abbreviated New Drug Application for levofloxacin oral solution USP, 25 mg/mL.

Although the incidence of nontuberculous mycobacterial (NTM) lung disease is increasing, and current treatment options are limited, certain NTM patients may find a potential treatment option in video-assisted thoracoscopic surgery.

The results of 2 studies indicate that patients who are overweight or obese have better mortality outcomes than patients who are at a normal weight when it comes to fighting off infectious diseases.